Reactive oxygen species are produced during exercise. The antioxidants prevent or limit tissue damages by these species in physiological conditions. In particular, ascorbate and urate scavenge peroxynitrite, which can alter the function of many molecules, including the lecithin-cholesterol acyltransferase (LCAT) enzyme involved in reverse cholesterol transport. The aims of the present study were to compare the plasma antioxidant response to an ergometric test (ET) in hypertensive and healthy subjects, evaluate the exercise-dependent nitrosative stress in plasma, and assess whether the LCAT activity is altered by the exercise. Plasma samples, prepared before and after ET from hypertensive or healthy volunteers, were analysed for their levels of ascorbate, urate, a-tocopherol, retinol, nitrotyrosine, and LCAT activity. The a-tocopherol and retinol levels did not significantly change in both groups during exercise, while the ascorbate level changed displaying higher increase in controls (+38.8%) than in hypertensives (+17.2%). In these patients, during ET, the urate and nitrotyrosine levels changed more than in normotensives (+13.5 and +40.6% vs À3.1 and +25.2%, respectively). The antioxidants effectively prevented loss or reduction of LCAT activity, as it was similar in hypertensives and normotensives, and did not change after ET. The results demonstrate that exercise is associated with enhanced protein nitrosation, and suggest that the ascorbate or urate levels increase to limit oxidative damage.
Introduction
Exercise increases the rate of oxygen consumption in humans up to 20-fold, and this can induce oxidative stress by generating an excess of oxygen free radicals. 1, 2 Under physiological conditions, the body has sufficient antioxidant reserve to counteract an increased production of free radicals. However, if the production of reactive oxygen species (ROS) is excessive, as observed during strenuous aerobic exercise, 3, 4 or if antioxidant defences are severely impaired, the balance between pro-oxidants and antioxidants may be altered and oxidative stress occurs. 5 Substantial evidence links several diseases, including hypercholesterolaemia, diabetes, hypertension, and atherosclerosis, to increased production of ROS. 5, 6 It has been suggested that antioxidants may inhibit atherogenesis and improve endothelial vascular function, preventing LDL oxidation and decreasing ROS production or release from cells. In particular, ascorbate (Asc) has been demonstrated to enhance the endothelium-derived NO activity and normalise vascular function in patients with coronary artery disease, and hypertension, and hypercholesterolaemia. 7, 8 It has been proposed that endothelial dysfunction associated with hypertension might be caused by augmented production of the superoxide anion, a radical impairing the endothelium ability to induce NOmediated relaxation of underlying smooth muscle cells. [9] [10] [11] [12] The rapid reaction of nitric oxide with superoxide generates a potent oxidising species, the peroxynitrite anion (ONOO À ), a powerful lipid, protein, and DNA oxidant, which can be detected by increased 3-nitrotyrosine (N-Tyr) level in injured tissues. 13, 14 N-Tyr residues have been recently identified also in human atherosclerotic plaques. 15 Two important peroxynitrite scavengers, Asc and urate, represent the major components of the physiological response to prevent oxidative stress, and their plasma levels during exercise might change in order to avoid ROS-induced biological damage. 14 In this context, when most of the cardiovascular risk factors are present, poor antioxidant defence or reduced NO availability can lead to endothelium dysfunction and promote atherosclerosis. 16 Removal of cholesterol from arterial tissue, a crucial step in limiting atherogenesis, may be obtained by high-density lipoprotein (HDL)-mediated reverse cholesterol transport. A key component of this pathway, the enzyme lecithin-cholesterol acyltransferase (LCAT, E.C. 2.3.1.43), is known to be altered by oxidative stress. In particular, LCAT is markedly inhibited by incubation with peroxynitrite. 17 Thiol oxidation of cysteine residues near the active site pocket was shown to decrease the enzyme activity. 18 Therefore, the ROS production associated with physical exercise could influence the efficiency of LCAT enzyme in eliminating the cholesterol excess from endothelial cells. Nevertheless, it is conceivable that the physiological antioxidant response to exercise can be enhanced to prevent or reduce loss of LCAT activity by either scavenging peroxynitrite or reducing ROS formation in the two compartments involved in the reverse cholesterol transport, namely the cell plasma membrane and the lipoprotein. 19 Different concentrations of major antioxidants were previously found before and after long-term exercises, such as marathon 20, 21 or an intense physical training 22, 23 or consecutive days of exercise. 24 The ergometric test (ET) represents a form of exercise with increasing physical effort and oxygen consumption. Thus, ET can be used to study exercise-induced changes in the level of main plasma antioxidants, such as Asc, urate, a-tocopherol (Toc), and retinol (Ret). 6 Urate and Asc are the major antioxidants in body fluids and the latter, in addition, restores the antioxidant properties of oxidised Toc. 6 Toc and Ret are scavengers of free radicals in lipid compartments such as cell plasma membrane and lipoproteins. 25 The purpose of this study was to compare the plasma antioxidant response to a cycle ET in hypertensive patients with that in healthy subjects. In addition, we report data on N-Tyr concentration and LCAT activity in hypertensives and normotensives, before and after exercise. The LCAT activity was evaluated in the light of the plasma level changes of the analysed antioxidants and N-Tyr.
Materials and methods

Materials
Chemicals of the highest purity, donkey anti-sheep horseradish peroxidase-conjugated (DAS-HRP) IgG, Supelcosil LC-18 column (5 mm particle size, 250 mm Â 4.6 mm), and HPLC standards were purchased from Sigma-Aldrich (Milan, Italy 
Plasma preparation
Venous peripheral blood was drawn into a heparinized tube (approximately 5 ml), and plasma was obtained by centrifugation (500 g; 15 min; 41C). All patients were informed about the use of their plasma for the analysis described here and gave their consent.
Subjects
A total of 11 patients with diagnosed essential arterial hypertension and 18 adult healthy subjects were enrolled. Subjects with hypercholesterolaemia, diabetes mellitus, cardiac and/or cerebral ischaemic vascular disease, impaired renal function, and other major pathologies were excluded from the study. The inclusion criteria for the hypertensive subjects were: age 30-65 years and previously diagnosed hypertension, normoglycaemia, no sign or symptoms for other cardiovascular disease, and no regular use of any drugs other than antihypertensive drugs. A complete medical examination was performed to exclude secondary forms of hypertension. The estimate duration of antihypertensive treatment in the patients was 8.5 7 7.8 years. Hypertensives with plasma levels of antioxidants (Asc, urate, Toc, Ret) significantly different from those of normal subjects (see pre-ET values in Table 1 ) were excluded from the study. The normal subjects were recruited among normotensive and normoglycaemic volunteers who used no medication and had no sign or symptoms of any disease. Subjects or patients smoking more than five cigarettes per day and/or consuming 460 g of ethanol per day were excluded from the study. Demographic and clinical data from patients and controls are reported in Table 1 .
Ergometric test
All subjects underwent cardiopulmonary and electrocardiographic examination before ET. The exercise programme was performed by cycling on the ergometer (model Ergocard, Esaote Biomedica, Milan, Italy) with a multistage incremental protocol. The test was performed with an initial workload of 25 W followed by stepwise (3 min) increments of 25 W at a constant pedalling frequency of 60 rpm until exhaustion. Exercise was stopped when the maximal theoretical heart rate was reached by each subject. Hypertensives and controls exercised for 9.7 7 0.7 min (pressure Â rate product ¼ 292 7 14 Â 10 2 mmHg Â bpm) and 9.6 7 0.6 min (pressure Â rate product ¼ 281 7 11 Â 10 2 mmHg Â bpm), respectively. The energy consumption was, for all subjects, higher than 7 MET. Blood samples were drawn from an antecubital vein, immediately before and at the end of exercise. The investigation conforms with the principles outlined in the Declaration of Helsinki.
LCAT assay
Plasma samples were processed for the determination of the LCAT activity, according to a previously described procedure. 26 In the enzyme assay, the conversion of 3 H-cholesterol to 3 H-cholesteryl esters was measured, and the activity was expressed as nanomoles of cholesterol incorporated per hour per millilitre of plasma. The inter-and intra-assay CVs for LCAT were 7.7% (N ¼ 6) and 3.2% (N ¼ 9), respectively.
Titration of N-Tyr in plasma proteins
Nitrated protein levels were determined by competitive ELISA, essentially according to a published procedure. 27 Major modifications were using TBS (130 mmol l À1 NaCl, 20 mmol l À1 Tris-HCl, pH 7.3) instead of PBS as buffer, sheep anti-N-Tyr IgG and DAS-HRP as primary and secondary antibodies, respectively. The extent of tyrosine nitration, in standard solutions of nitrated BSA, was determined by measuring the absorbance at 430 nm, using the molar extinction coefficient of 4500 mol l À1 cm À1 at pH 9.6 28 : 9.3 residues of N-Tyr per BSA molecule were detected. A standard curve was obtained by different amounts of nitrated BSA in TBS supplemented with 0.25% BSA and 0.05% Tween 20. The concentration of plasma-nitrated proteins inhibiting the anti-N-Tyr antibody binding to nitrated BSA was determined on the basis of the standard calibration curve, and expressed as equivalents of nitrated BSA. 28 The inter-and intra-assay CVs were 6.3% (N ¼ 8) and 2.0% (N ¼ 8), respectively.
Titration of antioxidants
Samples used for titration of Asc and urate were prepared by mixing 120 ml of ice-cold ethanol with 30 ml of plasma. The mixture was shaken, centrifuged (12 000 g; 1 min; 41C), and the protein pellet was discarded. The column (Nucleosil 100-NH 2 ) was injected with 20 ml of supernatant. Chromatography was carried out at a flow rate of 0. À1 EDTA, at concentrations ranging from 5 to 160 mmol l À1 and 15 to 500 mmol l À1 , respectively. Inter-and intraassay CVs were 2.8% (N ¼ 7) and 1.9% (N ¼ 7), respectively, for the Asc titration, and 3.4% (N ¼ 7) and 1.8% (N ¼ 7), respectively, for the urate titration.
Samples for titration of Ret and Toc were prepared by mixing 15 ml of plasma with 100 ml of ice-cold isopropanol : methanol (1 : 1, v : v). The mixture was vigorously shaken and, after centrifugation (12 000 g; 1 min; 41C), 20 ml of the supernatant were analysed by HPLC. A reverse-phase column (Nova-Pack C18) with isopropanol : methanol : water (46.25 : 46.25 : 7.5, v : v : v) as mobile phase was chosen for the chromatography. The analysis was carried out at 0.2 ml min À1 and a programmable fluorescence spectrometer (RF-551) was used. In particular, Ret was detected by setting l EX ¼ 325 nm and l EM ¼ 465 nm from 0 to 5 min, while Toc was detected by l EX ¼ 295 nm and l EM ¼ 335 nm from 5 to 8 min. Standard solutions of Toc (N ¼ 12; 0.1-3.6 mmol l À1 ) and Ret (N ¼ 12; 25-800 nmol l À1 ) were prepared as previously published 29 to obtain calibration curves (r 2 X0.9997). Inter-and intra-assay CVs were 4.9% (N ¼ 7) and 1.2% (N ¼ 7), respectively, for the Ret titration, and 2.6% (N ¼ 7) and 0.1% (N ¼ 7), respectively, for the Toc titration.
Statistical analysis
The samples for measuring the N-Tyr concentration and the LCAT activity were processed at least in triplicate. The N-Tyr titration could not be 
Results
Titration of antioxidants
Plasma samples were obtained from normotensive (N ¼ 18) and hypertensive (N ¼ 11) subjects both before (pre-ergometric test, pre-ET) and after (postergometric test, post-ET) a short-term intense exercise. Haemoglobin-free samples of pre-ET and post-ET plasma were analysed for their content of Toc, Ret, Asc, and urate. Wide concentration ranges were found for each antioxidant ( Table 2) . The values of Ret and Toc concentration in pre-ET plasma did not significantly differ from those in post-ET plasma. Conversely, in the plasma from both hypertensive and normal subjects, the Asc level significantly increased during exercise. The statistical analysis of the data from the two groups indicates that the Asc increase, expressed as per cent of the values in pre-ET plasma, was higher in the normotensive subjects than in the hypertensive ones (38.79 7 7.709 vs 17.20 7 4.59%; P ¼ 0.025; Figure 1a ). This result provides evidence that Asc hepatic release or Asc recycling overcomes Asc consumption. In particular, the lower increase in hypertensives suggests that either release and recycling were lower or consumption was higher than in normotensives. The analysis of urate level in normotensives and hypertensives showed different results. In fact, the urate levels, during exercise, did not significantly change in normotensives (À3.109 7 2.91%), while increased in hypertensives (13.46 7 6.47%; Po0.01), as shown in Figure 1b .
N-Tyr concentration in plasma samples
N-Tyr is widely used as a marker of oxidative stress induced by peroxynitrite. 13 The N-Tyr concentration was determined in both pre-ET and post-ET plasma by ELISA, using an anti-N-Tyr antibody as described in the Methods section. The data obtained indicate that the physical effort promoted an increase in NTyr plasma concentration in both healthy (N ¼ 15) and hypertensive (N ¼ 10) subjects (Table 2) . These increases, expressed as per cent of the values in pre-ET plasma, were used to calculate mean values in each group (Figure 2 ). The N-Tyr production was found to be significantly higher in the plasma of hypertensive patients than in normal plasma (40.64 7 5.672 vs 25.23 7 3.9%; P ¼ 0.014). The results indicate that hypertension is associated with enhanced protein nitrosation in plasma, thus suggesting that the short-term exercise induced Figure 4 ). These results suggest that metabolic processes, different in hypertensives and normotensives, influence the biochemical mechanisms underlying the urate and peroxynitrite production, and the Asc consumption or recycling.
LCAT assay in plasma of hypertensives and normotensives, before and after exercise
The enzyme LCAT can lose its activity of removing cholesterol from vessel wall or subendothelium when the cells are attacked by nitrosative stress. 18, 30 The assay of the LCAT activity was therefore used as a tool to evaluate the efficiency of urate or Asc to scavenge the peroxynitrite anion produced during the short-term physical effort. The enzyme activity was determined in the plasma of hypertensives (N ¼ 6) and normotensives (N ¼ 10), before and after exercise. Significant differences in LCAT activity between the group of patients and that of healthy subjects were not detected both in pre-ET and post-ET plasma. However, the enzyme activity slightly changed in single individuals. These changes were analysed together with the exercise-dependent changes in N-Tyr level and, in both groups, no correlation was found ( Figure 5 ). This result indicates that the nitrosative stress, even though affecting the structure of tyrosine residues in plasma proteins, including LCAT, did not affect the enzyme active site, and suggests that the observed level of the peroxynitrite scavengers was sufficiently increased, during exercise, to prevent fall or loss of LCAT function. 
Discussion
The pathogenesis of hypertension is a multifactorial process that involves the interaction of genetic and environmental factors. Several lines of evidence suggest that hypertension is associated with enhanced oxidative stress. 9, [31] [32] [33] In particular, it has been proposed that superoxide anions might trigger the development of hypertension, by inactivating endothelium-derived nitric oxide, thus impairing its beneficial and protective effects on the vessel wall. 9 In essential hypertension, both the plasma levels of lipid peroxides and the leucocyte production of superoxide anion or hydrogen peroxide were found increased, 32 while the levels of antioxidants, including Toc, were found decreased. 31, 32 A body of information on the improvement of endotheliumdependent vasodilation by antioxidants is available, and confirms that increased ROS production plays a major role in the pathogenesis of hypertension.
In the present investigation, we studied, in hypertensives and healthy subjects, the plasma antioxidant response to a short but intense exercise, a condition associated with increased blood pressure and requiring vasodilation.
The experiments described here were carried out on plasma from healthy and hypertensive subjects, having at rest the same levels of Toc, Ret, Asc, and urate. The plasma levels of these antioxidants were measured after ET. No significant change in the levels of the two liposoluble antioxidants was observed, thus suggesting that the oxidants produced during exercise did not alter the redox status of the plasma lipid compartment, that is circulating lipoproteins. On the contrary, increased levels of Asc were found after exercise. This result is in accordance with the data previously reported on the increase of Asc concentration, in healthy individuals, following intense exercise. 23, 24 Patients with hypertension, compared with control group, displayed a lower increase of Asc levels while a significant higher increase of urate levels. It is known that Asc, which is dependent on dietary intake, cannot be synthesised in humans. 34 Thus, the plasma level increase of this important antioxidant must result from its release from the liver, 35 or the regeneration of its oxidised forms (Asc free radical and dehydroascorbate) on hepatocyte and erythrocyte plasma membrane. [36] [37] [38] A possible interpretation of the lower Asc increase in hypertensive patients is that, in these patients, either more Asc is oxidised, or less oxidised Asc is recycled in the reduced form, or both circumstances occur. In these patients, an excess of hypoxantine, which is produced in the muscle during exercise, 2, 39 has been suggested to be converted to urate by the enzyme xantine oxidase. 40 The enzyme catalyses, in a single reaction, not only the synthesis of urate, but also that of the superoxide radical. As a matter of fact, recent evidence suggests that hypertensive patients exhibit in plasma a significantly higher production of this free radical than control subjects. 31, 32 Excess endothelial superoxide generation has been in turn suggested to be one of the factors causing hypertension. 5 The decreased NO-dependent vasodilator function in hypertension was mostly related to oxidative stress brought about by superoxide radicals. [41] [42] [43] Superoxide very rapidly reacts with NO forming a powerful oxidant, the peroxynitrite anion. 13 It should be noted, in this frame, that superoxide is scavenged by Asc, 25 and this explains why increased Asc levels were found improving the endothelium-dependent vasodilation 44 and agrees well with our data on the lower Asc increase in the hypertensive state. A positive correlation between Asc and N-Tyr changes was found in normotensives, and a negative correlation between urate and N-Tyr changes was found in hypertensives. These results suggest that metabolic processes, different in hypertensives and normotensives, influence the biochemical mechanisms underlying the urate and peroxynitrite production, and the Asc consumption or recycling. Urate might be more effective than Asc in scavenging peroxynitrite, and the negative correlation in hypertensives might represent the level of urate consumption when different amounts of peroxynitrite are produced. In this frame, in normotensives, the changes in urate levels might be too low to counteract the increased production of peroxynitrite effectively. In normotensives, Asc seems to be consumed in lower amounts or recycled in higher amounts than in hypertensives. Such a higher amount might depend on increased recycling by erythrocytes or hepatocytes. It cannot be excluded that NO might stimulate the Asc recycling cells. A lower stimulation in hypertension might be explained as the superoxide production, in these conditions, is enhanced and expected to increase the synthesis of peroxynitrite while decrease the levels of free NO. Many molecular species are attacked by peroxynitrite and, among them, tyrosine and cysteine residues of proteins are the major targets. 27, 45 The concentration of N-Tyr represents a footprint of the peroxynitrite formation, and its measure is widely used to evaluate the level of nitrosative stress. 13 Peroxynitrite is produced in the plasma of hypertensives and normotensives during the short-term physical effort, as increased N-Tyr levels in circulating proteins were found. Thus Asc, although displaying increased levels in both hypertensives and normotensives, and urate, displaying increased levels in hypertensives, were unable to scavenge all the peroxynitrite molecules synthesised. This suggested that protein function in plasma might be altered owing to the peroxynitrite attack. The enzyme LCAT, which plays a crucial role in cholesterol reverse transport, can be actually attacked and degraded by peroxynitrite, as a cysteine residue involved in the catalytic mechanism is a known nitrosation target. 18, 30 In addition, LCAT contains a number of tyrosine residues, which may undergo nitration and possibly affect LCAT activity. 17 We show here that the enzyme function is not decreased or lost during exercise, in conditions promoting the formation of N-Tyr, and suggest that the increase of the peroxynitrite scavengers is sufficient to protect the LCAT thiol group responsible for the catalytic activity. It seems conceivable that the thiol residue, located in the pocket of the active site, is sufficiently protected from the peroxynitrite attack.
In conclusion, our results suggest that the defence demand to scavenge peroxynitrite and other ROS might mainly or mostly be satisfied by Asc. However, if the amount of this scavenger is not sufficient to lower the level of superoxide or other radicals, as could occur in essential hypertension, urate synthesis and excretion into the circulation might increase just to restore the physiological balance between antioxidants and oxidants. Thus, measuring the increase of urate and Asc concentrations, in the plasma of healthy or hypertensive individuals, might provide information on the risk or progression of hypertension, respectively.
